These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26820102)

  • 41. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.
    Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q
    Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-7-5p suppresses tumor metastasis of non-small cell lung cancer by targeting NOVA2.
    Xiao H
    Cell Mol Biol Lett; 2019; 24():60. PubMed ID: 31832068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-1246 suppresses the metastasis of breast cancer cells by targeting the DYRK1A/PGRN axis to prevent the epithelial-mesenchymal transition.
    Wang P; Chen W; Zhang Y; Zhong Q; Li Z; Wang Y
    Mol Biol Rep; 2022 Apr; 49(4):2711-2721. PubMed ID: 35059968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis.
    Wang J; Li M; Han X; Wang H; Wang X; Ma G; Xia T; Wang S
    Cell Death Dis; 2020 Jul; 11(7):500. PubMed ID: 32620748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
    Stinson S; Lackner MR; Adai AT; Yu N; Kim HJ; O'Brien C; Spoerke J; Jhunjhunwala S; Boyd Z; Januario T; Newman RJ; Yue P; Bourgon R; Modrusan Z; Stern HM; Warming S; de Sauvage FJ; Amler L; Yeh RF; Dornan D
    Sci Signal; 2011 Aug; 4(186):pt5. PubMed ID: 21868360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.
    Zeng J; Wei M; Shi R; Cai C; Liu X; Li T; Ma W
    Tumour Biol; 2016 Feb; 37(2):2729-35. PubMed ID: 26408179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.
    Zhai L; Ma C; Li W; Yang S; Liu Z
    Mol Carcinog; 2016 Dec; 55(12):1990-2000. PubMed ID: 26618772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25.
    Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y
    Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer.
    Liang YJ; Wang QY; Zhou CX; Yin QQ; He M; Yu XT; Cao DX; Chen GQ; He JR; Zhao Q
    Carcinogenesis; 2013 Mar; 34(3):713-22. PubMed ID: 23250910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-205-5p Downregulation and
    Kalinkova L; Nikolaieva N; Smolkova B; Ciernikova S; Kajo K; Bella V; Kajabova VH; Kosnacova H; Minarik G; Fridrichova I
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
    Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
    World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
    Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H
    Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.
    Wang Q; Cheng Y; Wang Y; Fan Y; Li C; Zhang Y; Wang Y; Dong Q; Ma Y; Teng YE; Qu X; Liu Y
    BMC Cancer; 2017 Jul; 17(1):492. PubMed ID: 28724364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.
    Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q
    Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA.
    Block CJ; Mitchell AV; Wu L; Glassbrook J; Craig D; Chen W; Dyson G; DeGracia D; Polin L; Ratnam M; Gibson H; Wu G
    Oncogene; 2021 Nov; 40(46):6430-6442. PubMed ID: 34608266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upregulation of microRNA-141 suppresses epithelial-mesenchymal transition and lymph node metastasis in laryngeal cancer through HOXC6-dependent TGF-β signaling pathway.
    Chen L; Sun DZ; Fu YG; Yang PZ; Lv HQ; Gao Y; Zhang XY
    Cell Signal; 2020 Feb; 66():109444. PubMed ID: 31629025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G; Liu M; Han H
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.